Des Plaines, IL, United States of America

Ariia A Bergmanis

This inventor holds 1 USPTO granted patent. Top assignee: G.d. Searle & Company. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ariia A Bergmanis. Retrieved from https://idiyas.com/inventor/ariia-a-bergmanis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ariia A Bergmanis: Innovator in iNOS Inhibition

Introduction

Ariia A Bergmanis is a notable inventor based in Des Plaines, IL (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that inhibit nitric oxide synthase.

Latest Patents

Ariia holds a patent for "Oxathiadiazole derivatives useful as iNOS inhibitors - 1,3-diazolino and 1,3-diazolidino heterocycle derivatives useful as nitric oxide synthase inhibitors." This patent highlights her innovative approach to creating effective therapeutic agents.

Career Highlights

Ariia is associated with G.D. Searle & Company, where she has been instrumental in advancing research in her field. Her work focuses on developing new compounds that can potentially lead to breakthroughs in treating various medical conditions.

Collaborations

Throughout her career, Ariia has collaborated with esteemed colleagues, including Donald W Hansen, Jr and Timothy J Hagen. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Ariia A Bergmanis is a pioneering inventor whose work in iNOS inhibition has the potential to impact the medical field significantly. Her contributions continue to inspire future innovations in medicinal chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…